Eligible participants were randomly allocated in a @:@ ratio to either antepartum prophylactic dose dalteparin ( @ international units once daily up to @ weeks ' gestation , and twice daily thereafter until at least @ weeks ' gestation ) or to no antepartum dalteparin ( control group ) .